uniQure announces FDA approval of first gene therapy for adults with hemophilia B - read this article along with other careers information, tips and advice on BioSpace
uniQure announces FDA approval of first gene therapy for adults with hemophilia B streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Global biotechnology leader CSL (ASX: CSL) today announced that the U.S. Food and Drug Administration (FDA) approved HEMGENIX® (etranacogene.
U S Food and Drug Administration approves CSL s HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia B prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
~ Historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy, and.